Form 4: Semler Scientific CFO Renae Cormier Reports Stock Option Grant
SEC Form 4 Filing
Renae Cormier, CFO of Semler Scientific, Inc., reported the acquisition of stock options on May 10, 2024.
Summary
- On May 10, 2024, Renae Cormier, the Chief Financial Officer of Semler Scientific, Inc., reported a transaction related to derivative securities.
- Cormier acquired stock options, granting the right to buy 15,000 shares of Semler Scientific's common stock at an exercise price of $22.92.
- These options vest over a four-year period, with 1/4th vesting on the first anniversary of the grant date and the remaining 3/4ths vesting monthly thereafter.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, indicating a neutral sentiment. It reflects routine compensation practices.
Positives
- The grant of stock options to the CFO aligns her interests with those of the shareholders, incentivizing her to improve the company's performance.
Industry Context
This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the compensation structure and equity ownership of key executives.
Stakeholder Impact
- The stock option grant aligns the CFO's interests with those of shareholders, potentially leading to decisions that benefit the company's long-term value.
Key Dates
| Date | Description |
|---|---|
| 05/10/2024 | Date of the stock option grant. |
| 05/10/2024 | Date of earliest transaction. |
| 05/10/2034 | Expiration date of the stock options. |
| 05/14/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.